CS

Candriam SCA Portfolio holdings

AUM $19.1B
1-Year Est. Return 27.91%
This Quarter Est. Return
1 Year Est. Return
+27.91%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.46B
AUM Growth
+$433M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
907
New
Increased
Reduced
Closed

Top Buys

1
+$59.9M
2
+$49.9M
3
+$49.5M
4
JD icon
JD.com
JD
+$44.8M
5
TMO icon
Thermo Fisher Scientific
TMO
+$40.8M

Top Sells

1
+$114M
2
+$102M
3
+$58.9M
4
BMY icon
Bristol-Myers Squibb
BMY
+$58.4M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$52M

Sector Composition

1 Healthcare 34.68%
2 Technology 20.98%
3 Consumer Discretionary 8.92%
4 Financials 8.6%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
826
– –
-40,000
827
– –
-682,927
828
– –
-46,467
829
– –
-17,000
830
– –
-27,128
831
– –
-1,065
832
– –
-52,355
833
– –
-39,000
834
– –
-9,523
835
– –
-277,700
836
– –
-15,723
837
– –
-26,239
838
– –
-3,959
839
– –
-39,027
840
– –
-212,406
841
– –
-9,873
842
– –
-5,000
843
– –
-2,189
844
– –
-9,029
845
– –
-155,531
846
– –
0
847
– –
-7,961
848
– –
-31,811
849
– –
-28,887
850
– –
-990,882
31 32 33
34
35